Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Full Year Trading Update

6 May 2022 07:00

RNS Number : 5370K
Revolution Beauty Group PLC
06 May 2022
 

For Immediate Release

6th May 2022

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Full Year Trading Update

Full Year Performance in line with market expectations

Strong FY22 Sales up c. 42% and adjusted EBITDA up c. 73%Record sales in Q4

 

Revolution Beauty Group plc (AIM: REVB), the global multi-brand, multi-category mass beauty innovator, is pleased to announce an update on trading for the year ended 28 February 2022.

 

Revolution Beauty has experienced continued positive momentum in H2 2022. The Group reports, subject to audit, revenue of c. £194mil up 42% versus 12mth ending Feb 2021, and Adjusted EBITDA c. £22mil up 73% versus 12mth ending Feb 2021. This performance was achieved against a background of inflationary pressures last year, including freight and pandemic related volatility.

 

Revolution Beauty's performance was underpinned by the company's geographic and category mix. Key highlights for the full year include:

 

· Record Q4: As indicated at our sales update in January, Revolution benefited from a record fourth quarter with global retailer expansions in Boots and Walgreens and ROW. Sales in the second half were up c. 44% year on year.

 

· UK Stores: In the UK, sales growth was strong, up c. 85% year on year, supported by post pandemic footfall recovery amongst retail partners, and a successful roll out of Makeup Revolution into Boots.

 

· US Stores: The USA is now Revolution's biggest single market at c. 20% mix of our business, delivering sales growth of c. 27% for the full year. This growth was achieved against a strong FY21 comparator, where Makeup Revolution was rolled out across Target for the first time.

 

· ROW Stores: The Rest of the World bounced back in FY22, with strong sales in the year, up c. +79%. ROW is now c. 35% of Revolution's global business.

 

· DTC: Our digital first strategy saw us gather insights, and "test and learn" new trends and products through the year, with successes including Plex Haircare and Fragrance. We also sold online over 100k units of our Christmas Advent Calendar across peak trade and continued to see encouraging results across our localised websites of the USA and Australia.

 

· Balanced Model: Our omnichannel route to market continued to balance the Revolution Beauty business model with growth across both digital and retail distribution. Digital platforms generated c.29% of sales with c.71% coming from retail stores in FY22.

 

 

Adam Minto, Group CEO, commented:

 

The Group delivered a strong full year performance, in line with expectations, and driven by the strength of our omnichannel route to market. We had a record fourth quarter in FY22 and saw strong broad-based sales growth across categories and geographies with revenue for the full year increasing by 42% against the previous year. The US has become our biggest single market in terms of store sales, while retail in the UK and the Rest of World continued to bounce back to pre-pandemic levels.

 

The success of our "In Real Life" make-up range, our co-created Sali Hughes skincare range, plus our successful launch this week into 2800 Walgreen Stores across the US, all demonstrate continued strong momentum into the first quarter of the year and give us real confidence as we move forward.

In a world where consumers are feeling the pressure from increased prices in almost every aspect of their lives, mass market beauty is perfectly positioned as the affordable choice. Like everyone, we remain mindful of the current economic climate, but we know Revolution's mission to offer quality products at affordable prices remains as relevant as ever. Looking ahead, Revolution remains confident as it pursues its strategy and continues its growth trajectory."

- Ends -

 

For further information:

Revolution Beauty Group plc

 

Adam Minto, Founder & CEO

 

Tom Allsworth, Founder & Executive Chairman

www.revolutionbeautyplc.com

 

Zeus 

(Nominated Adviser & Broker)

 

Investment Banking

 

Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

Equity Capital Markets

Tel: +44 (0) 20 3829 5000

Dominic King / Ben Robertson

www.zeuscapital.co.uk

   

 

Media enquiries:

Headland Consultancy

Rosh Field / Will Smith / Marta Parry-Jones

 

Tel: +44 (0)7872 350428

Tel: +44 (0)7884 742400

Revolutionbeauty@headlandconsultancy.com

 

 

 

About Revolution Beauty

 

Revolution Beauty is a global mass beauty and personal care business which operates a multi brand, multi category strategy and sells its products both direct-to-consumer (DTC) via its e-commerce operations, and in physical and digital retailers through wholesale relationships.

 

Today, the Group has a retail footprint of c.15,000 doors across leading retail chains in the UK, USA and other international markets. Revolution Beauty has access to a wide customer base, predominantly aged between 16 and 35, through its digital partners and own DTC platform. It has established and invested to streamline its supply chain with its own manufacturing facility in the UK, and third-party warehousing facilities across the UK, USA and Australia. The Group has offices in the UK, USA, New Zealand and Germany. Revolution Beauty currently employs 411 people.

 

The total mass beauty market was worth $219bn in 2019 and is expected to grow to $274bn over the next 3 years, driven by a new marketing era dominated by Social Media and influencers. Revolution Beauty has been a leading innovator building a significant global following across social channels, enabling it to spot trends and respond quickly to consumer demand.

 

Revolution Beauty strategy

 

Revolution Beauty Group is disrupting the traditional beauty market through products that are more accessible to more people. Through its digital-first strategy, Revolution Beauty brings trend-led products to market faster than competitors. We invest in innovative marketing strategies designed to appeal to a wider audience, and offer products combining quality, inclusivity, innovation and affordability.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVAELIEIIF
Date   Source Headline
7th Mar 20232:00 pmRNSRevised deferred consideration for Medichem
21st Feb 20237:00 amRNSUpdate on FY22 Audit
13th Jan 20237:00 amRNSOutcome of Independent Investigation
16th Dec 20222:35 pmRNSDirectorate Change
28th Nov 20222:24 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSAppointment of CEO
25th Nov 20224:27 pmRNSTR-1: Standard notification of major holdings
9th Nov 20229:05 amRNSDirectorate Change
27th Oct 20225:30 pmRNSSuspended Companies Notice – Deletions
14th Oct 20227:00 amRNSUpdate on Independent Investigation
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
7th Sep 20227:00 amRNSTR-1: Standard notification of major holdings
1st Sep 20227:30 amRNSSuspension - Revolution Beauty Group plc
30th Aug 20227:00 amRNSUpdate on Publication of Final Results
19th Aug 20222:30 pmRNSFurther update on the Group’s audit
17th Aug 20226:20 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:15 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:00 pmRNSTR-1: Standard notification of major holdings
17th Aug 20227:05 amRNSStrategic Investment in Revolution Beauty Group
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
12th Aug 20221:55 pmRNSTR-1: Standard notification of major holdings
11th Aug 20224:41 pmRNSSecond Price Monitoring Extn
11th Aug 20224:35 pmRNSPrice Monitoring Extension
11th Aug 202211:05 amRNSUpdate on the Group’s audit
11th Aug 202210:10 amRNSTR-1: Standard notification of major holdings
5th Aug 20221:20 pmRNSTR-1: Standard notification of major holdings
3rd Aug 20223:45 pmRNSTR-1 Standard notification of major holdings
2nd Aug 20227:00 amRNSTrading update and change to results date
30th Jun 20227:00 amRNSCorporate Broker Appointment and Notice of Results
17th Jun 20227:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
12th May 20227:00 amRNSAppointment of Chief Financial Officer
11th May 202211:40 amRNSHolding(s) in Company
6th May 20227:00 amRNSFull Year Trading Update
25th Feb 20227:00 amRNSAcquisition
23rd Feb 20225:50 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSTrading Update
24th Nov 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSAcquisition of Medichem Manufacturing
27th Sep 20217:00 amRNSH1 Trading Update and Notice of Results
20th Aug 202111:47 amRNSIssue of Shares under Share Incentive Plan & TVR
23rd Jul 202112:08 pmRNSImplementation of Long Term Incentive Plan
22nd Jul 20215:35 pmRNSNotification of Major Holdings
21st Jul 20217:00 amRNSNotification of Major Holdings
20th Jul 20215:59 pmRNSDirector Dealing
19th Jul 20217:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.